Found 11 matching trials
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection PHASE3 This study is a randomized, open-label, multicentric, phase III trial condu...
Show More Location
Centre Hospitalier Universitaire
Learn More & Join Trial
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors PHASE1 Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Show More Location
Ellison Clinic at Saint John's
Learn More & Join Trial
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. N/A A assessment of the efficacy of first-/second-line endocrine therapies ± ta...
Show More Location
N.N. Blokhin National Medical Research Center of Oncology
Learn More & Join Trial
Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. PHASE2 This study is a multicenter, international, open-label phase II study. Base...
Show More Location
EHS LCC Blida, Medical Oncology Center
Learn More & Join Trial
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer PHASE2 PATRICIA is a phase II, open-label, multicentre, Simon's two-stage-design s...
Show More Learn More & Join Trial
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases PHASE2 The purpose of this neoadjuvant trial is to evaluate efficacy and toxicity ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer PHASE2 The majority of patients (pts) with breast cancer have hormone receptor pos...
Show More Status
Active Not Recruiting
Location
University of Miami
Learn More & Join Trial
Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging PHASE2 This study evaluates HER2-PET/CT-guided dynamic optimization of neoadjuvant...
Show More Location
Multiple Locations
Learn More & Join Trial